Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma

NCT02715297 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT02715297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02715297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
Lead sponsor
Technical University of Munich
Phase
Phase 2
Overall status
Unknown status
Start date
February 29, 2016
Completion date
February 28, 2023
Enrollment
162 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma